Clinical Trials Directory

Trials / Completed

CompletedNCT02020148

Can Oxytocin Level Predict Postpartum Depression?

Can Prenatal Plasma Oxytocin Concentration Predict Likelihood of Postpartum Depression? An Opportunity for Early Intervention and Prevention in a Vulnerable Population

Status
Completed
Phase
Study type
Observational
Enrollment
68 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this research study is to understand the relationship between the hormone oxytocin and postpartum mood.

Detailed description

Postpartum depression (PPD) affects some one in five new mothers, and adversely influences maternal adaptation to motherhood. While it is known that women with a prior history of depression, or depression during pregnancy, are at elevated risk for postpartum depression, many women with no prior history of depression or other risk factors go on to develop depression in the postpartum period. Considering the grave consequences of postpartum depression on maternal infant bonding and childhood psychological development, it is critical to develop reliable methods to identify which women, who are not depressed during pregnancy, will become depressed after delivery. The biological pathways leading to depression at any time in life, including around pregnancy, are still poorly characterized. Oxytocin (OT), a hormone involved in delivery and lactation, has received recent attention regarding its additional role in maternal emotions and care taking behaviors after birth. The primary goal is explore the relationship between plasma oxytocin and postpartum mood.

Conditions

Timeline

Start date
2013-12-01
Primary completion
2015-06-01
Completion
2015-08-01
First posted
2013-12-24
Last updated
2023-10-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02020148. Inclusion in this directory is not an endorsement.